Real-World Deep Brain Stimulation Outcomes Using Directional DBS Systems with Multiple Independent Current Control
Objective: Here, we report the real-world clinical outcomes associated with the use of DBS systems capable of directionality and Multiple Independent Current Control (MICC) in…Sleep assessment with Fitbit4 in Parkinson’s disease
Objective: The aim of this study is to evaluate the sleep characteristics in PD patients using Fitbit4, as a wearable objective measure of sleep for…FEASIBILITY OF A SMARTPHONE-BASED APPROACH TO ACCESS GAIT PARAMETERS AND DETECT FALL RISK IN PARKINSON’S DISEASE
Objective: Determine incidence of falls in a group of PD patients and correlate their clinical characteristics with parameters of gait kinetics obtained through videos recorded…Smartphone-based mobility assessment in Parkinson’s disease: A validity study
Objective: To create and test a smartphone application that enables self-administration of Timed-up-and-go (TUG) test, under both normal and dual-task conditions. Background: The TUG test…The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic
Objective: To analyse the impact of the COVID-19 pandemic on the young MDS members assessing their satisfaction with the MDS virtual educational tools. Background: The…Is past use of statins associated with lower incidence of Parkinson’s disease?
Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…“I’ve got cataracts and can’t read the information sheet about the medication you have given me”*
Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials
Objective: The 3DT initiative of the Critical Path for Parkinson’s Consortium (CPP) aims to advance the regulatory maturity of digital biomarkers, for clinical studies in…Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson’s disease and motor fluctuations
Objective: This post-hoc analysis evaluated the impact of 3-month earlier versus postponed initiation of opicapone (OPC) in patients with Parkinson’s disease (PD) and motor fluctuations.…Effects of Opicapone on Sleep in Patients with Parkinson’s Disease and Motor Fluctuations
Objective: To assess the effects of opicapone (OPC: 50 mg, once-daily) on sleep in patients with Parkinson’s disease (PD) and motor fluctuations. Background: OPC is…
- « Previous Page
- 1
- …
- 407
- 408
- 409
- 410
- 411
- …
- 436
- Next Page »